Pitavastatin fails to lower serum lipid levels or inhibit gastric carcinogenesis in helicobacter pylori-infected rodent models.

scientific article published on 21 July 2009

Pitavastatin fails to lower serum lipid levels or inhibit gastric carcinogenesis in helicobacter pylori-infected rodent models. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1158/1940-6207.CAPR-09-0082
P698PubMed publication ID19622613
P5875ResearchGate publication ID26686203

P50authorTetsuya TsukamotoQ43285168
P2093author name stringLiang Shi
Masae Tatematsu
Takuji Tanaka
Takeshi Toyoda
Shinji Takasu
Toshiko Kumagai
Hisayo Ban
Naoki Hirano
P433issue8
P921main subjectHelicobacter pyloriQ180556
P304page(s)751-758
P577publication date2009-07-21
P1433published inCancer Prevention ResearchQ2665103
P1476titlePitavastatin fails to lower serum lipid levels or inhibit gastric carcinogenesis in helicobacter pylori-infected rodent models
P478volume2

Reverse relations

cites work (P2860)
Q41125099Anti-Inflammatory Effects of Capsaicin and Piperine on Helicobacter pylori-Induced Chronic Gastritis in Mongolian Gerbils.
Q36715105Chemoprevention of gastrointestinal cancer: the reality and the dream
Q31125021Gene expression analysis of a Helicobacter pylori-infected and high-salt diet-treated mouse gastric tumor model: identification of CD177 as a novel prognostic factor in patients with gastric cancer
Q38056644Helicobacter pylori infection and gastric carcinogenesis in rodent models
Q39222060Role of Helicobacter pylori in Gastric Neoplasia
Q33612306Statin Therapy Is Associated with Reduced Risk of Peptic Ulcer Disease in the Taiwanese Population
Q35885119Statins Attenuate Helicobacter pylori CagA Translocation and Reduce Incidence of Gastric Cancer: In Vitro and Population-Based Case-Control Studies

Search more.